Abstract:Persistent hyperglycemia represents a major metabolic complication of diabetes, which may cause endothelial cell dysfunction and apoptosis. microRNAs are novel biomarkers, modulators and therapeutic targets for disease. The microRNA miR-221 is expressed in human umbilical vein endothelial cells (HUVEC). Insulin-like growth factor 1 (IGF-1) is an important survival factor for multiple cell types. This study was to investigate whether high glucose (HG) induces endothelial dysfunction and apoptosis through altering the microRNA expression and IGF-1 signaling. The mirVana qRT-PCR miRNA detection assay showed that exposure to glucose for 24 h dose-dependently (up to 25 mM) increased miR-221 expression by 2.6 ± 0.5 folds (p<0.05). HG treatment decreased c-kit protein expression (58 ± 7 % decrease vs. control at 48 h) assessed by flow cytometry. The treated HUVEC had a reduced capacity for wound healing responded to stem cell factor (SCF, the ligand of c-kit). SCF-induced HUVEC migration potential was also reduced significantly by exposure to high dose of glucose. As estimated by prediction algorithms, c-kit, but not IGF-1, was identified as the target of miR-221. Transfection of HUVEC with 2′-O-methyl antisense inhibitory oligonucleotide (AMO-221) downregulation of miR-221 led to attenuation of the glucose’s effect on the c-kit expression, SCF-induced migration and wound healing in HUVEC. Prolonged glucose exposure (25 mM, 96 h) induced apoptosis of HUVEC assessed by Death ELISA (O.D. values = 0.49 ± 0.06 in glucose group vs. 0.12 ± 0.07 in control, p<0.01). Addition of IGF-1 (30 ng/ml) blocked the glucose-induced apoptosis, whereas AMO-221 did not attenuate the apoptosis. In addition, the anti-apoptotic effects of IGF-1 was attenuated by PI3 kinase inhibitor LY294002 (15 uM) (IGF-1 + glucose + PI3 kinase inhibitor vs. IGF-1 + glucose = 0.45 ± 0.07 vs. 0.15 ± 0.05 O.D. values). Our data demonstrate that downregulation of miR-221 attenuates HG-induced reduction of c-kit, wound healing and migration of HUVEC, and enhanced IGF-1 signaling prevents HG-induced apoptosis. Thus, reducing miR-221 expression and activating IGF-1 signaling pathway may be a useful strategy to prevent diabetic-induced endothelial dysfunction and apoptosis. This research has received full or partial funding support from the American Heart Association, AHA South Central Affiliate (Arkansas, New Mexico, Oklahoma & Texas).

MicroRNA-221 Regulates High Glucose-Induced Endothelial Dysfunction.

Abstract 5441: the Roles for MicroRNA-221 and IGF-1 Signaling in Regulation of High Glucose-Induced Endothelial Dysfunction and Apoptosis

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction.

RETRACTED: Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction (Retracted Article)

Lentivirus-mediated Overexpression of CD97/ADGRE5 Reverses Dysregulated High Glucose-Induced Endothelial Cell Migration

Hyperglycemia and Advanced Glycation End Products Regulate Mir-126 Expression in Endothelial Progenitor Cells

Downregulation of lncRNA MIR181A2HG by high glucose impairs vascular endothelial cell proliferation and migration through the dysregulation of the miRNAs/AKT2 axis

Downregulation of miR-210-3p attenuates high glucose-induced angiogenesis of vascular endothelial cells via targeting FGFRL1

High Glucose Induces Vascular Contraction Through Mitochondrial Membrane Potential (mmp)‐miro‐mlc Pathway

High Glucose Induces Dysfunction of Human Umbilical Vein Endothelial Cells by Upregulating Mir-137 in Gestational Diabetes Mellitus.

Human Circular RNA‑0054633 Regulates High Glucose‑induced Vascular Endothelial Cell Dysfunction Through the Microrna‑218/roundabout 1 and Microrna‑218/heme Oxygenase‑1 Axes

1476-PUB: The Stimulation of High Glucose Can Downregulate Expression of miR-223-3p in HUVECs, Which May Undergo Endothelial–Myofibroblast Transition

Downregulation of MicroRNA-4463 Attenuates High-Glucose- and Hypoxia-Induced Endothelial Cell Injury by Targeting PNUTS

MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function.

Effect of the Diabetic Environment on the Expression of MiRNAs in Endothelial Cells: Mir-149-5p Restoration Ameliorates the High Glucose-Induced Expression of TNF-α and ER Stress Markers

Mir‐217 Alleviates High‐glucose‐induced Vascular Smooth Muscle Cell Dysfunction Via Regulating ROCK1

High-glucose treatment regulates biological functions of human umbilical vein endothelial cells via Sirt1/FOXO3 pathway

Mir‑132 Inhibits High Glucose‑induced Vascular Smooth Muscle Cell Proliferation and Migration by Targeting E2F5.

miR-503/Apelin-12 mediates high glucose-induced microvascular endothelial cells injury via JNK and p38MAPK signaling pathway

MicroRNA-200a Improves Diabetic Endothelial Dysfunction by Targeting KEAP1/NRF2.